Poor adhesion of fentanyl transdermal patches may mimic end-of-dosage failure after 48 hours and prompt early patch replacement in hospitalized cancer pain patients

CONTEXT: Renewal of fentanyl transdermal patch (transdermal therapeutic system [TTS]) should occur every 3 days (72 hours) according to manufacturer’s guidelines. Some studies mentioned patients reporting end-of-dose failure, and thus, some authors recommend shortening the interval of application to...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnet, Isabelle, Schacher, Sabrina, Balmer, Eva, Koeberle, Dieter, Hersberger, Kurt E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108613/
https://www.ncbi.nlm.nih.gov/pubmed/27877065
http://dx.doi.org/10.2147/JPR.S116091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108613/
https://www.ncbi.nlm.nih.gov/pubmed/27877065
http://dx.doi.org/10.2147/JPR.S116091

Ejemplares similares